Cargando…

Gastric myeloid sarcoma: A case report

BACKGROUND: Myeloid sarcoma (MS) is a rare hematologic malignancy defined as an extramedullary tumor of immature granulocytic cells. It can occur as primary or de novo and be associated with myelodysplasia or myeloproliferative neoplasms. The most frequent locations are the skin, lymph nodes and bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rioja, Patricia, Macetas, Jackeline, Luna-Abanto, Jorge, Tirado-Hurtado, Indira, Enriquez, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546661/
https://www.ncbi.nlm.nih.gov/pubmed/34733617
http://dx.doi.org/10.5306/wjco.v12.i10.960
_version_ 1784590231354212352
author Rioja, Patricia
Macetas, Jackeline
Luna-Abanto, Jorge
Tirado-Hurtado, Indira
Enriquez, Daniel J
author_facet Rioja, Patricia
Macetas, Jackeline
Luna-Abanto, Jorge
Tirado-Hurtado, Indira
Enriquez, Daniel J
author_sort Rioja, Patricia
collection PubMed
description BACKGROUND: Myeloid sarcoma (MS) is a rare hematologic malignancy defined as an extramedullary tumor of immature granulocytic cells. It can occur as primary or de novo and be associated with myelodysplasia or myeloproliferative neoplasms. The most frequent locations are the skin, lymph nodes and bones. The case of a patient with a diagnosis of primary granulocytic de novo gastric MS is reported. CASE SUMMARY: A 19-year-old female patient with MS, whose abdominal computed tomography showed a bulky tumor of 16.5 cm in the gastric chamber with infiltration in the retroperitoneal, pancreatic and bile duct region; the histological study showed gastric mucosa diffusely infiltrated by mononucleated cells and the immunohistochemistry expressed myeloperoxidase. After receiving induction chemotherapy based on the 3 + 7 regimen (daunorubicin/cytarabine), the patient developed severe hematological toxicity and neutropenic typhlitis which required a prolonged medical treatment. She presented a rapid disease progression. Although she received supportive treatment, the patient died. CONCLUSION: Gastric primary de novo MS is a rare and aggressive course neoplasm, fostering knowledge is very important to decide its management and to promote more approaches focused on understanding this pathology and its particularities in our population.
format Online
Article
Text
id pubmed-8546661
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-85466612021-11-02 Gastric myeloid sarcoma: A case report Rioja, Patricia Macetas, Jackeline Luna-Abanto, Jorge Tirado-Hurtado, Indira Enriquez, Daniel J World J Clin Oncol Case Report BACKGROUND: Myeloid sarcoma (MS) is a rare hematologic malignancy defined as an extramedullary tumor of immature granulocytic cells. It can occur as primary or de novo and be associated with myelodysplasia or myeloproliferative neoplasms. The most frequent locations are the skin, lymph nodes and bones. The case of a patient with a diagnosis of primary granulocytic de novo gastric MS is reported. CASE SUMMARY: A 19-year-old female patient with MS, whose abdominal computed tomography showed a bulky tumor of 16.5 cm in the gastric chamber with infiltration in the retroperitoneal, pancreatic and bile duct region; the histological study showed gastric mucosa diffusely infiltrated by mononucleated cells and the immunohistochemistry expressed myeloperoxidase. After receiving induction chemotherapy based on the 3 + 7 regimen (daunorubicin/cytarabine), the patient developed severe hematological toxicity and neutropenic typhlitis which required a prolonged medical treatment. She presented a rapid disease progression. Although she received supportive treatment, the patient died. CONCLUSION: Gastric primary de novo MS is a rare and aggressive course neoplasm, fostering knowledge is very important to decide its management and to promote more approaches focused on understanding this pathology and its particularities in our population. Baishideng Publishing Group Inc 2021-10-24 2021-10-24 /pmc/articles/PMC8546661/ /pubmed/34733617 http://dx.doi.org/10.5306/wjco.v12.i10.960 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Report
Rioja, Patricia
Macetas, Jackeline
Luna-Abanto, Jorge
Tirado-Hurtado, Indira
Enriquez, Daniel J
Gastric myeloid sarcoma: A case report
title Gastric myeloid sarcoma: A case report
title_full Gastric myeloid sarcoma: A case report
title_fullStr Gastric myeloid sarcoma: A case report
title_full_unstemmed Gastric myeloid sarcoma: A case report
title_short Gastric myeloid sarcoma: A case report
title_sort gastric myeloid sarcoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546661/
https://www.ncbi.nlm.nih.gov/pubmed/34733617
http://dx.doi.org/10.5306/wjco.v12.i10.960
work_keys_str_mv AT riojapatricia gastricmyeloidsarcomaacasereport
AT macetasjackeline gastricmyeloidsarcomaacasereport
AT lunaabantojorge gastricmyeloidsarcomaacasereport
AT tiradohurtadoindira gastricmyeloidsarcomaacasereport
AT enriquezdanielj gastricmyeloidsarcomaacasereport